Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Reata Pharmaceuticals Inc (RETA)  
$172.36 0.00 (0.00%) as of 4:30 Mon 9/25


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 31,730,000
Market Cap: 5.47(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $90.01 - $172.36
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Reata Pharmaceuticals is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapies. Co. focuses on therapeutics for the treatment of diseases with few or no approved therapies. Co.'s main programs are in rare forms of chronic kidney disease (CKD) and a rare neurological disease. Co.'s primary product candidates include bardoxolone methyl (bardoxolone) in patients with CKD caused by Alport syndrome and omaveloxolone in patients with a neurological disorder called Friedreich's ataxia. Both bardoxolone and omaveloxolone activate the transcription factor Nrf2 to normalize mitochondrial function, restore redox balance, and resolve inflammation.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 139,124 598,993
Total Sell Value $0 $0 $22,953,536 $63,982,389
Total People Sold 0 0 8 10
Total Sell Transactions 0 0 15 53
End Date 2024-03-17 2023-12-15 2023-06-16 2022-06-16

   
Records found: 393
  Page 16 of 16  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Bass James Edward Director   –       •      –    2016-06-01 4 A $0.00 $0 I/I 4,903 1,448     -
   Bass James Edward Director   –       •      –    2016-06-01 4 B $11.00 $264,400 D/D 23,000 25,585 2.39     -
   Bass James Edward Director   –       •      –    2016-06-01 4 A $0.00 $0 D/D 2,585 7,585     -
   Meyer Colin John See Remarks   •       –      –    2016-06-01 4 B $11.00 $110,000 D/D 10,000 20,172 2.74     -
   Meyer Colin John See Remarks   •       –      –    2016-06-01 4 A $0.00 $0 D/D 10,172 10,172     -
   Stone Dennis K. Director   –       •      –    2016-06-01 4 A $0.00 $0 D/D 2,622 2,622     -
   Huff James Warren See Remarks   •       •      –    2016-06-01 4 A $0.00 $0 I/I 3,166 3,166     -
   Huff James Warren See Remarks   •       •      –    2016-06-01 4 B $11.00 $1,254,000 D/D 114,000 176,657 2.81     -
   Huff James Warren See Remarks   •       •      –    2016-06-01 4 A $0.00 $0 D/D 62,657 62,657     -
   Cpmg Inc   •       •       •   2016-06-01 4 B $11.43 $3,194,224 I/I 251,553 252,706 0.01     -
   Cpmg Inc   •       •       •   2016-06-01 4 A $0.00 $0 I/I 110,856 134     -
   Cpmg Inc   •       •       •   2016-06-01 4 A $0.00 $0 D/D 113 113     -
   Mcgaughy R Kent Jr   •       •       •   2016-06-01 4 B $11.43 $3,194,224 I/I 251,553 362,522 0.01     -
   Mcgaughy R Kent Jr   •       •       •   2016-06-01 4 A $0.00 $0 I/I 118,579 110,969     -
   Mcgaughy R Kent Jr   •       •       •   2016-06-01 4 A $0.00 $0 D/D 25,004 25,004     -
   Traweek James W Jr   •       •       •   2016-06-01 4 B $11.43 $3,194,224 I/I 251,553 362,522 0.01     -
   Traweek James W Jr   •       •       •   2016-06-01 4 A $0.00 $0 I/I 138,553 110,969     -
   Traweek James W Jr   •       •       •   2016-06-01 4 A $0.00 $0 D/D 35 35     -

  393 Records found
  Previous  10  11  12  13  14  15  16    
  Page 16 of 16
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed